Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth factor β3 in myelinating Schwann cells

Journal of Neuroscience

Volumn 23, Issue 19, 2003, Pages 7269-7280

  Huijbregts, Richard P H ^a   Roth, Kevin A ^a   Schmidt, Robert E ^b   Carroll, Steven L ^a  

^a University of Alabama at Birmingham   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

erbB receptor; Glial growth factor; Neuregulin; Neuropathy; Schwann cell; Schwannoma

Indexed keywords

GLIA GROWTH FACTOR BETA 3; GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG; DNA; ISOPROTEIN; NERVE PROTEIN; NRG1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATION; GENE OVEREXPRESSION; GLIA CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NERVE SHEATH TUMOR; NEURAL CREST; NEURILEMOMA; NONHUMAN; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN FAMILY; SCHWANN CELL; SCIATIC NERVE; STEM CELL; TRANSGENIC MOUSE; AGE; ANIMAL; ANIMAL LAMENESS; AUTONOMIC GANGLION; BIOSYNTHESIS; CYTOLOGY; GENETICS; HINDLIMB; HYPERPLASIA; INNERVATION; METABOLISM; MYELIN SHEATH; NEUROLOGIC DISEASE; PARALYSIS; PATHOLOGY; PHYSIOLOGY; TRIGEMINUS GANGLION;

AGE FACTORS; ANIMALS; DNA; GANGLIA, AUTONOMIC; HINDLIMB; HYPERPLASIA; LAMENESS, ANIMAL; MICE; MICE, TRANSGENIC; MYELIN SHEATH; NERVE SHEATH NEOPLASMS; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NEUREGULIN-1; PARALYSIS; PROTEIN ISOFORMS; SCHWANN CELLS; SCIATIC NERVE; TRIGEMINAL GANGLION;

EID: 0042237909     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-19-07269.2003     Document Type: Article

References (60)

1. Adlkofer K, Lai C (2000) Role of neuregulins in glial cell development. Glia 29:104-111.
2. Anderson LM, Hagiwara A, Kovatch RM, Rehm S, Rice JM (1989) Transplacental initiation of liver, lung, neurogenic and connective tissue tumors by N-nitroso compounds in mice. Fund Appl Toxicol 12:604-620.
3. Arpornchayanon O, Hirota T, Itabashi M, Nakajima T, Fukuma H, Beppu Y, Nishikawa K (1984) Malignant peripheral nerve tumors: a clinicopathological and electron microscopic study. Jpn J Clin Oncol 14:57-74.
4. Asbury AK (1967) Schwann cell proliferation in developing mouse sciatic nerve: a radioautographic study. J Cell Biol 34:735-743.
5. Baron-Van Evercooren A, Gansmuller A, Gumpel M, Baumann N, Kleinman HK (1986) Schwann cell differentiation in vitro: extracellular matrix deposition and interaction. Dev Neurosci 8:182-196.
6. Bermingham-McDonogh O, Xu Y-T, Marchionni MA, Scherer SS (1997) Neuregulin expression in PNS neurons: isoforms and regulation by target interactions. Mol Cell Neurosci 10:184-195.
7. Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA, Pilotti S (2001) Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab Invest 81:833-844.
8. Brockes JP, Breakefield XO, Martuza RL (1986) Glial growth factor-like activity in Schwann cell tumors. Ann Neurol 20:317-322.
9. Buzard GS, Enomoto T, Hongyo T, Perantoni AO, Diwan BA, Devor DE, Reed CD, Dove LF, Rice JM (1999a) neu mutation in schwannomas induced transplacentally in Syrian golden hamsters by N-nitrosoethylurea: high incidence but low allelic representation. J Cancer Res Clin Oncol 125:529-540.
10. Buzard GS, Enomoto T, Anderson LM, Perantoni AO, Devor DE, Rice JM (1999b) Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea. J Cancer Res Clin Oncol 125:653-659.
11. s mice. J Neuropathol Exp Neurol 57:915-929.
12. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA (1997) Expression of neuregulins and their putative receptors, ErbB2 and ErbB3, is induced during Wallerian degeneration. J Neurosci 17:1642-1659.
13. Chen MS, Bermingham-McDonogh O, Danehy Jr FT, Nolan C, Scherer SS, Lucas J, Gwynne D, Marchionni MA (1994) Expression of multiple neuregulin transcripts in postnatal rat brains. J Comp Neurol 349:389-400.
14. 0. Neuron 16:309-319.
15. Cheng L, Esch FS, Marchionni MA, Mudge AW (1998) Control of Schwann cell survival and proliferation: autocrine factors and neuregulins. Mol Cell Biol 12:141-156.
16. Danielson PE, Forss-Petter S, Brow MAD, Calavetta L, Douglass J, Milner RJ, Sutcliffe JG (1988) p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
17. Dickersin GR (1987) The electron microscopic spectrum of nerve sheath tumors. Ultrastruct Pathol 11:103-146.
18. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR (1995) Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation and maturation of rat Schwann cell precursors. Neuron 15:585-596.
19. Druckrey H, Ivankovic S, Preussmann R (1966) Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210:1378-1379.
20. Erlandson RA (1985) Peripheral nerve sheath tumors. Ultrastruct Pathol 9:113-122.
21. Erlandson RA, Woodruff JM (1982) Peripheral nerve sheath tumors: an electron microscopic study of 43 cases. Cancer 49:273-287.
22. 0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. Eur J Neurosci 11:1577-1586.
23. Felts PA (1999) Neuregulins in Schwann cell development. Neuroscientist 5:8-11.
24. Fischbach GD, Rosen KM (1997) ARIA: a neuromuscular junction neuregulin. Annu Rev Neurosci 20:429-458.
25. Frohnert PW, Stonecypher MS, Carroll SL (2003) Constitutive activation of the neuregulin-1/erbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line. Glia 43:104-118.
26. Garratt AN, Britsch S, Birchmeier C (2000a) Neuregulin, a factor with many functions in the life of a Schwann cell. Bioessays 22:987-996.
27. Garratt AN, Voiculescu O, Topilko P, Charnay P, Birchmeier C (2000b) A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J Cell Biol 148:1035-1046.
28. Goodearl ADJ, Davis JB, Mistry K, Minghetti L, Otsu M, Waterfield MD, Stroobant P (1993) Purification of multiple forms of glial growth factor. J Biol Chem 268:18095-18102.
29. Grinspan JB, Marchionni MA, Reeves M, Coulaloglou M, Scherer SS (1996) Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16:6107-6118.
30. Gutmann DH (2001) The neurofibromatoses: when less is more. Hum Mol Genet 10:747-755.
31. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57.
32. Herrera GA, Pinto de Moraes H (1984) Neurogenic sarcomas in patients with neurofibromatosis (von Recklinghausen's disease): light, electron microscopy and immunohistochemistry study. Virchows Arch 403:361-376.
33. Kimura H, Fischer WH, Schubert D (1990) Structure, expression and function of a schwannoma-derived growth factor. Nature 348:257-260.
34. Kourea HP, Orlow I, Scheithauer BW, Cordon-Cardo C, Woodruff JM (1999) Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas. Am J Pathol 155:1855-1860.
35. Kruger GM, Mosher JT, Bixby S, Joseph N, Iwashita T, Morrison SJ (2002) Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 35:657-669.
36. Kwon YK, Bhattacharyya A, Alberta JA, Giannobile WV, Cheon K, Stiles CD, Pomeroy SL (1997) Activation of erbB2 during Wallerian degeneration of sciatic nerve. J Neurosci 17:8293-8299.
37. Leong ASY, Vinyuvat S, Suthipintawong C, Leong FJ (1997) Patterns of basal lamina immunostaining in soft-tissue and bony tumors. Appl Immunohistochem Mol Morphol 5:1-7.
38. Lorimier P, Mezin P, Labat Moleur F, Pinel N, Peyrol S, Stoebner P (1992) Ultrastructural localization of the major components of the extracellular matrix in normal rat nerve. J Histochem Cytochem 40:859-868.
39. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldassare M, Hiles I, Davis JB, Hsuan JJ, Totty NF, Otsu M, McBurney RN, Waterfield MD, Stroobant P, Gwynne D (1993) Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362:312-318.
40. Menon AG, Anderson KM, Riccardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Freiman RN, Lee JK, Li FP, Barker DF, Ledbetter DH, Kleider A, Martuza RL, Gusella JF, Seizinger BR (1990) Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci USA 87:5435-5439.
41. Meyer D, Yamaai T, Garratt A, Riethmacher-Sonnenberg E, Kane D, Theill LE, Birchmeier C (1997) Isoform-specific expression and function of neuregulin. Development 124:3575-3586.
42. Morris JK, Lin W, Hauser C, Marchuk Y, Getman D, Lee K-F (1999) Rescue of the cardiac defect in erbB2 mutant mice reveals essential roles of erbB2 in peripheral nervous system development. Neuron 23:273-283.
43. Nielsen GP, Stemmer-Rachamimov AO, Ino Y, Moller MB, Rosenberg AE, Louis DN (1999) Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol 155:1879-1884.
44. Nikitin AY, Ballering LAP, Lyons J, Rajewsky MF (1991) Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci USA 88:9939-9943.
45. Parada LF (2000) Neurofibromatosis type 1. Biochim Biophys Acta 1471:M13-M19.
46. Perantoni AO, Rice JM, Reed CD, Watatani M, Wenk ML (1987) Activated neu oncogene sequences in primary tumors of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosourea. Proc Natl Acad Sci USA 84:6317-6321.
47. Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH (2001) NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol 159:57-61.
48. Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Patrick J, Steinbach JH, Culp W, Brandt BL (1974) Clonal cell lines from the rat central nervous system. Nature 249:224-227.
49. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ (1994) Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77:349-360.
50. Takeuchi A, Ushigome S (2001) Diverse differentiation in malignant peripheral nerve sheath tumours associated with neurofibromatosis-1: an immunohistochemical and ultrastructural study. Histopathology 39:298-309.
51. Taxy JB, Battifora H, Trujillo Y, Dorfman HD (1981) Electron microscopy in the diagnosis of malignant schwannoma. Cancer 48:1381-1391.
52. Topilko P, Murphy P, Charnay P (1996) Embryonic development of Schwann cells: multiple roles for neuregulins along the pathway. Mol Cell Neurosci 8:71-75,
53. Urich H, Tien RD (1998) Tumors of the cranial, spinal and peripheral nerve sheaths. In: Russell and Rubinstein's pathology of tumors of the nervous system (Bigner DD, McLendon RE, Bruner JM, eds), pp 141-193. New York: Oxford UP.
54. Vang R, Biddle DA, Harrison WR, Heck K, Cooley LD (2000) Malignant peripheral nerve sheath tumor with a t(X;18): a synovial sarcoma variant? Arch Pathol Lab Med 124:864-867.
55. Wechsler W, Rice JM, Vesselinovitch SD (1979) Transplacental and neonatal induction of neurogenic tumors in mice: comparison with related species and with human pediatric neoplasms. Natl Cancer Inst Monogr 51:219-226.
56. Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey AI, Roberts T, Van Dyke T, Wetmore C, Chiu I-M, Giovannini M, Guha A, Higgins RJ, Marino S, Radovanovic I, Reilly K, Aldape K (2002) Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene 21:7453-7463.
57. Wolpowitz D, Mason TBA, Dietrich P, Mendelsohn M, Talmage DA, Role LW (2000) Cysteine-rich domain isoforms of the Neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 25:79-91.
58. Woodruff JM, Kourea HP, Louis DN, Scheithauer BW (2000) Malignant peripheral nerve sheath tumour (MPNST). In: Pathology and genetics of tumours of the nervous system (Kleihues P, Cavenee WK, eds), pp 172-174. Lyon, France: International Agency for Research on Cancer.
59. Young P, Suter U (2001) Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease. Brain Res Rev 36:213-221.
60. Zanazzi G, Einheber S, Westreich R, Hannocks M-J, Bedell-Hogan D, Marchionni M, Salzer JL (2001) Glial growth factor/neuregulin inhibits Schwann cell myelination and induces demyelination. J Cell Biol 152:1289-1299.